scispace - formally typeset
C

Cillian De Gascun

Researcher at University College Dublin

Publications -  69
Citations -  1584

Cillian De Gascun is an academic researcher from University College Dublin. The author has contributed to research in topics: Medicine & Population. The author has an hindex of 16, co-authored 58 publications receiving 1067 citations. Previous affiliations of Cillian De Gascun include Beaumont Hospital & Frimley Park Hospital.

Papers
More filters
Journal ArticleDOI

Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient- and sequence-level meta-analysis

Soo-Yon Rhee, +72 more
- 07 Apr 2015 - 
TL;DR: Most TDR strains in SSA and SSEA arose independently, suggesting that ARV regimens with a high genetic barrier to resistance combined with improved patient adherence may mitigate TDR increases by reducing the generation of new ARV-resistant strains.
Journal ArticleDOI

Global and regional molecular epidemiology of HIV-1, 1990–2015: a systematic review, global survey, and trend analysis

Joris Hemelaar, +181 more
TL;DR: The distribution of HIV-1 subtypes and recombinants changed over time in countries, regions, and globally as well as at a global level during 2005-15, where subtype B increased, subtypes A and D were stable, and subtypes C and G and CRF02_AG decreased.
Journal ArticleDOI

HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics

TL;DR: The association of subtype with demographic parameters suggests highly compartmentalized epidemics, determined by social and behavioural characteristics of the patients, suggests they acquired their infection there or in Europe from compatriots.
Journal ArticleDOI

The duration of infectiousness of individuals infected with SARS-CoV-2.

TL;DR: Evidence from a limited number of studies indicates that patients with severe-to-critical illness or who are immunocompromised, may shed infectious virus for longer, but patients with mild- to-moderate illness are highly unlikely to be infectious beyond 10 days of symptoms.
Journal ArticleDOI

Human Polyomavirus Reactivation: Disease Pathogenesis and Treatment Approaches

TL;DR: This review summarises the human polyomaviruses with particular emphasis on pathogenesis in those directly implicated in disease aetiology and the therapeutic options available for treatment in the immunocompromised host.